Immunization

Healthy People 2020, the national health promotion and disease intervention initiative, set the goal influenza vaccination rate in the community at 70%. Despite this goal, reports show that vaccination rates are way under expectations at 44%.

Young children are disproportionately affected by rotavirus, and it is a more severe disease for them.

New progress made towards the development of an HIV vaccine.

The rubella virus stays in the body of patients with severe deficiencies in their immune defenses, making them more susceptible to side effects.

A historic clinical trial testing the efficacy of an experimental HIV vaccine regimen gets underway this week in South Africa.

Gary Marshall, MD, professor of pediatrics at the University of Louisville School of Medicine, explains how immunization recommendations are made.

Gary Marshall, MD, professor of pediatrics at the University of Louisville School of Medicine, discusses the challenges health care professionals face in implementing vaccine recommendations.

Gary Marshall, MD, professor of pediatrics at the University of Louisville School of Medicine, talks about invasive disease prevention.

Gary Marshall, MD, professor of pediatrics at the University of Louisville School of Medicine, discusses misconceptions about vaccinations.

Although potential Zika virus vaccine candidates have shown promise in their early stages, emerging cases of the virus spreading throughout the United States have created urgency for the development of vaccination and therapeutic options.

To completely understand pneumococcal vaccines and appreciate the progress in this area, pharmacists need to review some history.

Gary Marshall, MD, professor of pediatrics at the University of Louisville School of Medicine, talks about why it's important for children to receive their recommended immunizations.

Each year, more than 80,000 Americans die of vaccine-preventable infections despite the wide availability of vaccines.

Flu season is under way, and, along with it, lots of confusion and unreliable information.

Flu season is under way, and, along with it, lots of confusion and unreliable information.

Viral loads were reduced in SIV-infected rhesus monkeys given an experimental vaccine in combination with an immune stimulant.

Human papilloma virus (HPV) causes about 31,000 cancers in women and men (and 4,000 deaths in women) annually.

Reduced reimbursements, Medicare Part D, and the Affordable Care Act have stimulated pharmacies to offer a broader palette of services.

Broadly neutralizing antibody delays viral rebound and opens doors for future HIV vaccines.

Human papillomavirus (HPV) causes 30,700 cervical, anal, oropharyngeal, penile, and vaginal/vulvar cancer cases annually. Multiple vaccines are available to combat at least the main oncogenic strains 16 and 18 that cause 90% of cancer cases.

According to the CDC, 4175 cases of Zika virus infections have been reported in the United States. So far, no vaccine exists to prevent the virus, but vaccine candidates are in the works.

Immunizing mouse models with Qa-1 derived from myelin prevented multiple sclerosis disease progression.

Top news of the day from across the health care landscape.

Although pharmacists administered vaccines historically, it was not until the late 1990s that pharmacy-based immunization programs were established in the modern community pharmacy setting.

Top news of the day from across the health care landscape.

Parts of a protein used in some HCV vaccine candidates are far too flexible to be successful.

Top news of the day from across the health care landscape.

Catalent Pharma Solutions and Moderna Therapeutics supports manufacturing of cancer vaccines.

The CDC is now recommending a 2-dose series of the HPV vaccination, rather than the previously recommended 3 doses, in children 11 to 12 years of age.